Filter
220
Text search:
FDA
Featured
Recommendations
21
New Publications
30
Language
Document type
No document type
103
Guidelines
63
Studies & Reports
27
Manuals
7
Fact sheets
7
Strategic & Response Plan
6
Training Material
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
8
Russia
8
Latin America and the Carribbean
7
Ghana
6
Philippines
4
Syria
4
South Africa
4
Ecuador
4
Uganda
3
Sudan
3
Yemen
3
Middle East and North Africa
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Congo, Democratic Republic of
2
USA
2
Ethiopia
2
South Sudan
2
Brazil
2
Colombia
2
Myanmar / Burma
2
Asia
2
Global
2
Nigeria
1
Zimbabwe
1
Iraq
1
Jordan
1
Germany
1
Kenya
1
Tanzania
1
Thailand
1
Argentina
1
Bolivia
1
Chile
1
Paraguay
1
Africa
1
Venezuela
1
Kazakhstan
1
France
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
57
Clinical Guidelines
26
Pharmacy & Technologies
12
Women & Child Health
5
Public Health
4
Key Resources
3
Toolboxes
COVID-19
47
Mental Health
30
TB
25
HIV
22
Pharmacy
13
AMR
12
Specific Hazards
7
Ebola & Marburg
4
Rapid Response
4
Planetary Health
4
NTDs
4
Refugee
3
NCDs
3
Malaria
2
2.0 Rapid Response
2
Cholera
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
second edition
Included more self-measured blood pressure (SMBP)-focused content with tools and resources.
Showcased more tools to find patients with potentially undiagnosed HTN.
Added new strategies that focus on chronic kidney disease testing and identification.
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Ciudad de México, México - 26 al 28 de mayo del 2014
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I
...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
English Manual and Guideline on World about Food and Nutrition, Health and Epidemic; published on 30 Nov 2021 by USAID
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat
...
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics
...
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы
...
Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11.
The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected
...
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
